PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) IPO
IPO
Priced at US$18.00 a share on Sep 24, 2020.
- Price
- US$18.00 a share
- Shares offered
- 11,765,000 shares of common stock
- Offering size
- US$211.8 million
- Underwriters' option
- Up to 1,764,750 more shares
- Underwriters
- Goldman Sachs & Co. LLC, BofA Securities, Cowen, Evercore ISI · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 26, 2020 |
| Filed publicly | Sep 4, 2020 |
| Amended twice | Newest Sep 24, 2020 |
| Shares registered with an exchange | Sep 21, 2020 |
| Declared effective by the SEC | Sep 24, 2020 |
| Final prospectus, with the price | Sep 25, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 25, 2020 |
| EFFECT · Notice that a registration is effective | Sep 24, 2020 |
| CERT · Exchange's certificate of listing | Sep 24, 2020 |
| S-1/A · Registration statement, amended | Sep 24, 2020 |
| CORRESP · Letter to the SEC | Sep 22, 2020 |
| CORRESP · Letter to the SEC | Sep 22, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 21, 2020 |
| CORRESP · Letter to the SEC | Sep 21, 2020 |
| S-1/A · Registration statement, amended | Sep 21, 2020 |
| UPLOAD · Letter from the SEC | Sep 17, 2020 |
| CORRESP · Letter to the SEC | Sep 11, 2020 |
| CORRESP · Letter to the SEC | Sep 4, 2020 |
| S-1 · Registration statement | Sep 4, 2020 |
| UPLOAD · Letter from the SEC | Aug 18, 2020 |
| DRS/A · Draft registration statement, amended | Aug 3, 2020 |
| DRSLTR · Letter to the SEC with a draft | Jul 31, 2020 |
| UPLOAD · Letter from the SEC | Jul 23, 2020 |
| DRS · Draft registration statement | Jun 26, 2020 |
From the cover of the final prospectus (424B4) filed Sep 25, 2020